Status:
COMPLETED
Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance
Lead Sponsor:
Ethicon Endo-Surgery
Conditions:
Abdominal Adhesions
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will document being able to successfully perform transgastric diagnostic peritoneoscopy (laparoscopic visualization) using a small collection of study surgical tools.
Eligibility Criteria
Inclusion
- Men and women will be enrolled in this study who:
- Are willing to give consent and comply with evaluation and treatment schedule;
- At least 18 years of age;
- Are a candidate for surgical weight loss intervention (i.e. meet ASMBS and NIH criteria) for an RYGB procedure at the Investigational site;
- Have a history of open abdominal surgery or laparoscopic abdominal surgery;
- ASA Classification I, II, or III (Appendix II); and
- Have a negative serum pregnancy test (for women of childbearing potential).
Exclusion
- Subjects will be excluded from the study for any of the following:
- Use of immunosuppressive medications (within 6 months of surgery; single burst dosages and inhalable steroids are acceptable);
- Acute cholecystitis or acute pancreatitis;
- Evidence of abdominal abscess or mass;
- Diffuse peritonitis;
- Use of anticoagulants or anti-platelet agents (use of daily cardio protective doses of aspirin, up to 81 mg/day, is acceptable and shall not constitute an exclusion criterion) or the presence of coagulopathy;
- Clinical diagnosis of sepsis;
- Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or that could impact the scientific integrity of the trial;
- Planned concurrent surgical procedure other than RYGB or adhesiolysis;
- Prior or planned major surgical procedure within 30 days before or after study procedure;
- Participation in any other investigational device or drug trial that has not completed the primary endpoint or that clinically interferes with the current study endpoints;
- Previously enrolled in the current series of 4 trials investigating the EES NOTES GEN1 Toolbox; or
- Any condition which precludes compliance with the study (Investigator discretion).
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00962650
Start Date
June 1 2009
End Date
October 1 2010
Last Update
March 29 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Medical Center
Columbus, Ohio, United States, 43210